SIMEON JAGGERNAUTH, DO
Osteopathic Medicine at Paysphere Cir, Chicago, IL

License number
Illinois 3898
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address 2
2330 Paysphere Cir, Chicago, IL 60674
10109 E 79Th St, Tulsa, OK 74133
Phone
(847) 746-4358

Personal information

See more information about SIMEON JAGGERNAUTH at radaris.com
Name
Address
Phone
Simeon Jaggernauth
2717 S Fir Ave, Broken Arrow, OK 74012
Simeon O Jaggernauth, age 54
2717 Fir Ave, Broken Arrow, OK 74012
(918) 451-5466
Simeon O Jaggernauth, age 54
2717 Fir Ave, Broken Arrow, OK 74012
(918) 451-5466

Organization information

See more information about SIMEON JAGGERNAUTH at bizstanding.com

Simeon Jaggernauth MD,DO

10109 E 79 St, Tulsa, OK 74133

Industry:
Internist
Phone:
(918) 286-5131 (Phone)
Simeon Jaggernauth

Professional information

Simeon Jaggernauth Photo 1

Dr. Simeon Jaggernauth, Tulsa OK - DO (Doctor of Osteopathic Medicine)

Specialties:
Hematology, Hematology & Oncology, Medical Oncology, Oncology
Address:
Cancer Treatment Centers of America at Southwestern Regional Medical Center
10109 E 79Th St, Tulsa 74133
(800) 524-4632 (Phone)
Certifications:
Internal Medicine, 2003, Medical Oncology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Cancer Treatment Centers of America at Southwestern Regional Medical Center
10109 E 79Th St, Tulsa 74133
Cancer Treatment Centers of America at Southwestern Regional Medical Center
10109 East 79Th St, Tulsa 74133
Philosophy:
A board-certified medical oncologist at Cancer Treatment Centers of America® at Southwestern Regional Medical Center, Dr. Jaggernauth finds it very important to consider the whole person when treating a patient for cancer. “When you're going through cancer, it's very important to understand that the body, the mind and the spirit are affected. This is not just a disease of a functional organ. This is a disease that will not only take its toll on your health, but also on your physical well being, your mind, and even your family.” For Dr. Jaggernauth part of treating the whole person is making sure that he or she understands and has a choice in the care that will be delivered. He believes it is important to explain to a patient the nature of their disease and how extensive it is. When they understand the implications behind the treatment that's going to be rendered, a patient can make a better decision. “We get their complete approval and understanding of anything that we do to them before they even engage in the treatment.” Behind treating the whole person and not just their disease is Dr. Jaggernauth’s commitment to the Mother Standard® of care. “What the 'Mother Standard' means to me is that we treat patients the same way we treat our mothers. We want them to feel completely at home. We want them to feel that this is how I would treat my mother, my brother, my sister or my closest friend.”
Education:
Medical School
Oklahoma State Univ Center For Health Sciences College Of Osteopathic Medicine
Graduated: 1999
Tulsa Regional Medical Center
Graduated: 2000
University Of Oklahoma
Graduated: 2003
University Of Louisville-James Graham Brown Cancer Center
Graduated: 2005
Oral Roberts University
Graduated: 1992


Simeon Jaggernauth Photo 2

Simeon Jaggernauth, Tulsa OK

Specialties:
Oncologist
Address:
10109 E 79Th St, Tulsa, OK 74133
Education:
Oklahoma State University Center for Health Sciences, College of Osteopathic Medicine - Doctor of Osteopathy
Saint Francis Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Simeon Jaggernauth Photo 3

Implantable Anti-Clogging Device For Maintenance Of Cerebrospinal Fluid Shunt Patency

US Patent:
2006023, Oct 19, 2006
Filed:
Apr 13, 2006
Appl. No.:
11/403318
Inventors:
Brett Osborn - Aventura FL, US
Simeon Jaggernauth - Tulsa OK, US
International Classification:
A61M 5/00, A61M 25/00, A61M 5/32
US Classification:
604009000, 604266000
Abstract:
Cerebrospinal fluid shunts (implantable devices for diversion of excess fluid from the brain to other body cavities) used to treat hydrocephalus often malfunction. A common etiology of shunt malfunction is obstruction of the distal catheter tip by accumulating particulate matter such as fat or proteinaceous debris. The proposed implantable device maintains the patency of the cerebrospinal fluid shunt with mechanical energy which serves to “scrub” the catheter lumen of particulate debris. The proposed device accomplishes this by housing a source of mechanical energy which is coupled to the external aspect of the catheter, itself traversing through a bore in the device. The energy source secondarily induces a waveform in the cerebrospinal fluid flowing through the catheter. The fluid waveform exerts shearing forces on the catheter wall and serves to disrupt the formation and accumulation of debris that potentially could occlude the shunt catheter, thereby maintaining patency of the shunt.


Simeon Jaggernauth Photo 4

Moisture Monitor Apparatus For A Fluid System

US Patent:
5563337, Oct 8, 1996
Filed:
Oct 12, 1994
Appl. No.:
8/322057
Inventors:
James C. Fitch - Tulsa OK
Simeon Jaggernauth - Tulsa OK
Kym Bergstrom - Wichita Falls TX
Assignee:
Diagnetics, Inc. - Tulsa OK
International Classification:
G01N 3320
US Classification:
73 61430
Abstract:
A moisture monitor apparatus for a fluid system. The apparatus includes a heater in fluid communication with the fluid system to heat the fluid in the fluid system. A microphone transmits sounds produced as the moisture vaporizes from heating and converts the sounds into electric voltage variations. The electric voltage variations are translated into quantitative data to determine the level of moisture in the fluid.